UNSPSC 85513164: Dilation of right common iliac artery with drug-eluting intraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to dilation of right common iliac artery with drug-eluting intraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 047C34Z

UNSPSC 85513164 Dilation of right common iliac artery with drug-eluting intraluminal device, percutaneous approach is a Commodity code that shows no recent state and local procurement activity aligned with its medical device scope. The six recent opportunities posted under this code—including independent medical evaluation services for pension disability determinations (City of Phoenix), surgical benefit carve-out programs for employee health plans (City of Long Beach), occupational medical surveillance (Washington State Department of Transportation), emergency and specialty care for detained youth (Harris County), pharmacy benefit management (Collier County), and temporary health professional staffing (Santa Clara County Health System)—are administrative health benefit procurement, occupational medicine, detention health services, pharmacy management, and clinical staffing. None involve percutaneous vascular intervention devices or their procurement by state and local buyers.

The code presents a significant taxonomy mismatch. State and local procurement under this nominal code reflects broader health administration and personnel services rather than medical devices themselves. No recent solicitation names device manufacturers, implantable product specifications, or hospital supply chain procurement typical of vascular intervention purchasing. Without evidence that state and local governments are actively acquiring drug-eluting stents or related percutaneous intervention devices through competitive procurement at the commodity level, this code does not represent a viable pursuit target for device or medical-product vendors at this time.